The latest articles and press releases.

 

Denver, Colorado, USA - December 3, 2007 more...

 
ELA Medical, Inc., a Sorin Group company, announced the first U.S. enrollment in the OPTION study (Optimal Anti-tachycardia Therapy in ICD Patients without Pacing Indications).  
   
Milan, Italy - October 11th, 2007 more...  
The Sorin Group announced today that Fred Hrkac has been appointed President, Cardiac Rhythm Management (CRM) Business Unit.  
   
Milan, Italy - September 21, 2007 more...  
Sorin Group: André-Michel Ballester appointed Chief Executive Officer.  
   
Tokyo, Japan - August 31, 2007  more...  
Sorin Group today announced the launch in Japan of the world's smallest line of ICDs: OVATIO.  
   
Denver, Colorado, USA - August 9, 2007  more...  
ELA Medical, Inc., a Sorin Group company announced the first U.S. implant in the NATURE study.  
   
Denver, Colorado, USA – May 11, 2007  more...  
The Sorin Group Announces Release Of 2007 Cardiac Rhythm Management (CRM) Product Performance Report.  
   
Denver, Colorado, USA – May 9, 2007  more...  
The Sorin Group announces European market release of REPLY™, the world’s smallest pacemaker.  
   
Paris, France – April 5, 2007  more...  
After the smallest defibrillator, Sorin is set to launch the world’s smallest pacemaker, confirming its desire for international growth.  
   
Milan, Italy – April 3, 2007  more...  
Sorin Group Names Dick Ames Senior Vice President for USA Cardiac Rhythm Management.  
   
Milan, Italy – March 1, 2007  more...  
The Sorin Group announced today CE Mark approval and first implants of REPLY™ pacemakers, the world’s smallest dual-chamber devices (8cc).  
   
Arvada, CO, USA – December 7, 2006  more...  
Sorin Group files pre-market approval application (PMA) with the United States Food and Drug Administration (FDA) seeking approval to market OVATIO™ CRT.  
   
Paris, France – November 14, 2006  more...  
Sorin Group initiates OPTION (Optimal Antitachycardia Therapy in ICD Patients without Pacing Indication) clinical study in Europe.  
   
Tokyo, Japan – October 4, 2006  more...  
SORIN GROUP expands its presence in the japanese market by introducing advanced defibrillation therapy.  
   
Paris, France – June 19, 2006  more...  
SORIN GROUP initiates multi-center "BITAC" study in europe.  
   
Arvada, CO, USA – June 15, 2006  more...  
SORIN GROUP announces first u.s. implants of ovatio dr implantable cardioverter defibrillators.  
   
Nice, France – June 13, 2006  more...  
SORIN GROUP highlights its latest innovations at cardiostim 2006.  
   
Boston, MA, USA – May 16, 2006  more...  
SORIN GROUP announces FDA approval of world's smallest implantable cardioverter defibrillator.  
   
Mannheim, Germany – April 20, 2006  more...  
SORIN GROUP stresses key role of innovative pacing technology in avoiding unnecessary ventricular pacing at Mannheim cardiology congress.  
   
Toronto, Canada – February 20, 2006  more...  
Ovatio, world's smallest implantable cardioverter defibrillator successfully implanted in Canada.  
   
Paris, France – January 16, 2006  more...  
SORIN GROUP launches world's smallest implantable cardioverter defibrillators in Europe.  
   
Paris, France – December 13, 2005  more...  
SORIN GROUP: 500 patients already have benefited from ELA's noninvasive innovative loop recorder.  
   
Milan, Italy – December 6, 2005  more...  
SORIN GROUP initiates clear study in Europe First Patient with NewLiving CHF Biventricular Pacemaker enrolled in the CLEAR study.  
   
Venice, Italy – October 4, 2005  more...  
SORIN GROUP innovates in the hemodynamic management of heart failure with the european introduction of its new generation cardiac resynchronization therapy products.